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The optimal treatment of septic shock remains controver- 
sial. In order to evaluate the efficacy of fluid resuscitation 
and corticosteroid administration, the following experi- 
mental study was undertaken. Forty-five puppies (1.6-5.4 
kg) were randomly divided into 9 groups generated by 
combining 3 different fluid regimens and 3 different timings 
for steroid administration. Arterial, venous, and pulmo- 
nary artery catheterization allowed continuous hemody- 
namic and metabolic monitoring. Septic shock was 
achieved by a slow bolus infusion of 109/kg Escherichia coli 
organisms. Methylprednisolonc (30 mg/kg) was adminis- 
tered either 30 min before bacterial infusion, at the time of 
shock, or 30 min after shock. When cardiac output 
dropped to less than 50% of control values, 1 of the 3 
following fluid resuscitation regimens was begun: 5 % albu- 
min in lactated Ringer's (LR) at 35 % of the estimated blood 
volume (EBV), LR at 105% EBV, or 5% albumin in LR at 
105% EBV. 
When all the groups were combined, early steroid treat- 
ment was more effective than delayed therapy, yielding 
respective survival rates of 47% and 7% at 180 rain. 
Similarly, the large-volume resuscitation groups achieved a 
43% survival rate compared to 13% for the smaller fluid 
protocols. Neither early steroid therapy nor large volume 
fluid therapy was shown by itself to increase survival, 
however. Despite steroid pretreatment, none of the puppies 
given the lower-volume infusion survived. Also, despite 
large-volume fluid resuscitation, there were no survivors 
when this was combined with steroid treatment that was 
delayed 30 min. Only by combining early steroid adminis- 
tration with large-volume fluid therapy was a markedly 
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increased survival rate achieved: 60% with simultaneous 
steroid treatment, and 70% with steroid pretreatment. 
A definite increase in animal survival has, therefore, 
been shown in the acute period of severe septic shock using 
a combination of high-volume fluid resuscitation and the 
early administration of steroids. 
Septic shock continues to be a clinical state that 
causes significant rates of  mortali ty.  The optimal 
t reatment  of  this pathological  condition remains a 
matter  of  cont roversy .  Quest ions about  the efficacy 
of  cort icosteroid therapy in treating shock states 
continue to be part  of  this cont roversy .  The use of  
fluid resuscitat ion and antibiotics has generally 
gained wider acceptance ,  however .  
Evaluat ion of  the relative importance of each 
component  of  therapy has been difficult. Many 
studies have poorly quanti tated the volume and 
kind of  fluid resuscitat ion used. The timing and type 
of steroid administrat ion has also varied. The use of  
shock models of  different types and variable sever-  
ity has further complicated the evaluation of previ- 
ous studies. 
Several  experimental  models  have suggested ben- 
eficial results f rom cort icosteroids alone [1-3], 
while others (including one f rom our laboratory) 
have shown no effect [4-6]. Other studies have 
suggested that steroid t rea tment  must  be combined 
with antibiotic therapy and fluid resuscitat ion to 
show a clear additional benefit [7, 8]. 
Through the use of  a puppy  model  of  live Esche- 
richia coli shock, identical to that used in our 
previous studies [5, 9], this exper iment  combines 
carefully quanti tated fluid resuscitat ion with a ste- 
roid administrat ion protocol  in order  to assess the 
efficacy of a var iety of  combinat ions of  these 2 
modalities. 
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Table 1. Experimental group protocols. 
Group number Regimen 
MPSS 30 min before E. coli; LR 
105% EBV 
MPSS 30 min before E. coli; 5% albu- 
min in LR 35% EBV 
MPSS 30 rain before E. coli; 5% albu- 
min in LR 105% EBV 
MPSS at shock; LR 105% EBV 
MPSS at shock; 5% albumin in LR 
35% EBV 
MPSS at shock; 5% albumin in LR 
105% EBV 
MPSS 30 rain after shock; LR 105% 
EBV 
MPSS 30 rain after shock; 5% albu- 
min in LR 35% EBV 
MPSS 30 min after shock; 5% albu- 
min in LR 105% EBV 
Materials  and Methods  
Forty-five mongrel puppies (1.6-5.4 kg) were ran- 
domly divided into 9 groups. A subcutaneous injec- 
tion of 50 ml/kg of normal saline ensured adequate 
hydration during a 12-hour fast before the experi- 
ment. Pentobarbital anesthesia (25 mg/kg) was giv- 
en and femoral artery and vein catheterization was 
performed bilaterally. A pediatric thermal dilution 
cardiac output catheter was passed through the 
pulmonary artery, and each animal was heparinized 
with 400 IU/kg of beef lung heparin. Baseline hemo- 
dynamic and metabolic measurements were made 
and repeated at regular intervals during the experi- 
ment. 
Treatment protocols for the 9 groups are shown 
in Table 1. Each puppy was subjected to a rapid 
infusion of 109 live E. coli (Dunwald strain 
B15:0125) per kilogram of body weight. Optical 
density measurements were made to determine the 
number of organisms infused. A 50% reduction in 
cardiac output was defined as shock. At the time of 
shock, each animal received fluid resuscitation. 
One of the 3 following treatments was used: lactat- 
ed Ringer's (LR) at 105% of the estimated blood 
volume (EBV); 5% albumin in LR at 35% of the 
EBV; or 5% albumin in LR at 105% of the EBV. 
EBV was calculated as 7% of the puppy's weight. 
In addition, each puppy received 30 mg/kg of intra- 
venous methylprednisolone sodium succinate 
(MPSS) either 30 min before bacterial infusion, at 
the time of shock, or 30 min after shock was 
documented. These combinations thus defined the 9 
experimental groups seen in Table 1. At the end of 
the 3-hour experimental period, the probability of 
long-term survival was assessed for each of the 
surviving animals. If the cardiac output was stable 
Table 2. Survival rates in experimental septic shock. 
Predicted 
Number Mean Survival long-term 
Group of weight rate at 180 survival rate 
number animals (kg) min (%) (%) 
1 5 3.1 80 40 
2 5 3.1 0 0 
3 5 4.2 60 40 
4 5 4.1 60 0 
5 5 4.5 20 0 
6 5 3.3 60 0 
7 5 3.8 0 0 
8 5 3.7 20 0 
9 5 3.8 0 0 
and measured at least 60% of the baseline value, 
long-term survival was predicted. The animals were 
sacrificed and correct placement of the pulmonary 
artery catheter was confirmed. 
Standard laboratory methods were used to mea- 
sure plasma glucose, cholesterol, triglycerides, free 
fatty acids, lactate, acid phosphatase, and arterial 
blood gases. The Wilcoxon signed rank test and 
Student's t-test were used for analysis, with p 
values of less than 0.05 considered significant. 
Results  
Survival 
Table 2 summarizes the general information about 
each group and lists the actual and predicted long- 
term survival. The 2 variables involved can be 
looked at individually and in combination. The first 
of these is the fluid resuscitation, and the second is 
the timing of the MPSS administration. 
The large-volume regimens, either with or with- 
out albumin, showed comparable survival results 
and each was statistically different from the smaller- 
volume resuscitation groups. When groups were 
combined, puppies given 105% of their EBV 
(groups 1, 3, 4, 6, 7, and 9) showed a survival rate of 
43% (Table 3). Only 13% of the animals receiving 
35% EBV treatment survived (groups 2, 5, and 8) 
(Table 4). 
The second variable, the timing of MPSS admin- 
istration, also brought about significant differences 
in survival rate. Steroid treatment 30 min after 
shock achieved only a 7% survival rate regardless 
of the type of fluid resuscitation (Table 5). The 
survival rate for animals treated at the time of shock 
or pretreated with MPSS was 47% (Table 6). De- 
spite pretreatment with MPSS, none of the small- 
volume resuscitation puppies survived. The corn- 
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Table 3. Collected groups' survival: Large-volume fluid 
resuscitation. 
Table 5. Collected groups' survival: Delayed-corticoste- 
roid treatment. 
Group Survival Group Survival 
number Regimen rate (%)~  number Regimen rate (%)a 
MPSS before E. coli; 105% EBV- 80 
LR 
MPSS before E. coli; 105% EBV- 60 
5% albumin in LR 
MPSS at shock; 105% EBV-LR 60 
MPSS at shock; 105% EBV-5% 60 
albumin in LR 
MPSS after shock; 105% EBV-LR 0 
MPSS after shock; 105% EBV-5% 0 
albumin in LR 
~Combined survival rate, 43%. 
Table 4. Collected groups' survival: Small-volume fluid 
resuscitation. 
Group Survival 
number Regimen rate (%)a 
MPSS before E. coli; 35% EBV-5% 0 
albumin in LR 
MPSS at shock, 35% EBV-5% albu- 20 
min in LR 
MPSS after shock; 35% EBV-5% 20 
albumin in LR 
~Combined survival rate, 13%. 
MPSS after shock; 105% EBV-LR 0 
MPSS after shock; 35% EBV-5% 20 
albumin in LR 
MPSS after shock; 105% EBV-5% 0 
albumin in LR 
aCombined survival rate, 7%. 
Table 6. Collected groups' survival: Early corticosteroid 
treatment. 
Group Survival 
number Regimen rate (%)a 
1 MPSS before E. coli; 105% EBV- 80 
LR 
2 MPSS before E. coli; 35% EBV- 0 
5% .albumin in LR 
3 MPSS before E. coli; 105% EBV- 60 
5% albumin in LR 
4 MPSS at shock; 105% EBV-LR 60 
5 MPSS at shock; 35% EBV-5% 20 
albumin in LR 
6 MPSS at shock; 105% EBV-5% 60 
albumin in LR 
aCombined survival rate, 47%. 
bined survival rate of  puppies similarly treated with 
MPSS, but given large-volume resuscitation 
(groups 1 and 3) was 70% (Table 7). Similar analysis 
showed that despite large-volume resuscitation in 
groups 7 and 9, there were no survivors when this 
treatment was combined with a delay in MPSS until 
30 min after shock. 
The groups receiving the combination of either 
steroid pretreatment  or t reatment at the time of 
shock with large-volume fluid resuscitation showed 
a 65% survival rate compared to only 8% for all 
other animals (Table 7). Seventy percent  of the 
steroid pretreated-high-volume fluid resuscitation 
group survived and 40% of these animals met 
criteria for predicted long-term survival at the com- 
pletion of the experimental  period (Table 8). No 
other  group yielded predicted long-term survivors. 
Hemodynamic  Studies 
Cardiac output (CO) (Fig. 1) decreased significantly 
to less than 50% of control values in each group. 
Following fluid resuscitation, cardiac output in- 
creased markedly in each group. The best recover-  
ies were seen with the larger-volume regimens, but 
differences were not statistically significant among 
groups. Following this initial improvement ,  outputs 
again deteriorated in each group of  animals. Only in 
group 6 puppies, who were given high-volume 5% 
albumin in LR resuscitation and steroids at the time 
of shock, was the cardiac output (CO) clearly 
statistically still elevated above shock levels at 15 
min after resuscitation. In the puppies pretreated 
with steroids and given large-volume fluid resusci- 
tation, the rate of  decline in CO was slowed. Each 
group given steroids after 30 min of shock showed 
statistically significant drops in CO 15-30 min fol- 
lowing fluid administration. While all other groups 
showed some decline, these differences were not 
statistically significant. The group given LR resus- 
citation at 35% EBV and steroids at the time of 
shock had a more rapid decline of CO than the 
large-volume resuscitation group. 
Mean blood pressures paralleled cardiac output 
measurements.  Each group showed a recovery  with 
fluid resuscitation. Only groups 1 and 3 (large- 
volume-steroid pretreatment  groups) showed sig- 
nificant improvement  in blood pressure when com- 
pared to the other  animals. The improvement  was 
short-lived in group 3 and slightly more sustained in 
group 1. 
Pulse pressure decreased with the bacteremia in 
all the animals. There was an initial recovery  with 
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Table 7. Collected groups' survival: Early corticosteroid 
treatment and large-volume fluid resuscitation. 
Group Survival 
number Regimen rate (%)a 
MPSS before E. coli; 105% EBV-LR 80 
MPSS before E. coli; 105% EBV-5% 60 
albumin in LR 
MPSS at shock; 105% EBV-LR 60 
MPSS at shock; 105% EBV-5% albu- 60 
rain in LR 
aGroups 1, 3, 4, 6: 65%; groups 2, 5, 7, 8, 9: 8%. 
Table 8. Predicted long-term survival. 
Group Survival 
number Regimen rate (%) 
MPSS before E. coli; 105% EBV-LR 40 
MPSS before E. coli; 105% EBV-5% 40 
albumin in LR 






20~- H 1 
0 ~--A5 
Control Shock 0 15 30 60 120 180 
Time (min.) 
Fig. 1. Cardiac output changes in group 1 (MPSS 30 min 
before E. coli; LR 105% EBV) and group 5 (MPSS at 
shock; 5% albumin in LR 35% EBV). These 2 groups 
represent the 2 ends of the spectrum of ftuid resuscitation. 
fluid resuscitation, followed by further decline in all 
the groups. 
Metabo l i c  S tud ies  
In each group, there was a significant acidosis 
measured after bacterial infusion. Mean pH values 
decreased to 7.0 or less in each group. The high- 
volume-ear ly  steroid treatment groups 1 and 3 
maintained blood pH better  than the other groups, 
but this trend was statistically significant only at a 
few points during the experiment  (Fig. 2). Lactic 
acidosis was documented in each animal. Mean 
values for each group rose to at least 60 mg/100 ml 
by the time fluid resuscitation was given. There 
were few statistically significant differences among 
groups. Group 1 had significantly lower lactate 
levels than groups 5, 7, and 9 at 30 rain after 
resuscitation (Fig. 3). 
Acid phosphatase levels rose significantly in each 
group. Variable responses were seen among the 
animals. There was a trend toward higher eleva- 
tions in the low-volume groups, which reached 
statistical significance when groups 2 and 5 were 
compared to group 1 at 60 min (Fig. 4). 
Serum glucose levels were quite variable and 
showed consistent decreases only as animals en- 
tered profound shock (Fig. 5). Group 2 did show a 
significant drop in values at 60 min. Cholesterol 
levels all decreased during the shock state. The 
magnitude of the change was not consistent,  how- 
ever, and no definite trends were identifiable. Free 
fatty acids showed little change, with only groups 2 
and 3 showing early rises that were statistically 
significant. Serum triglycerides also showed no 
definite trends. Group 1 showed significant declines 
at 60 and 120 min and group 2 showed early 
significant elevations. Arterial PO2 and PCO2 were 
quite stable during the experimental  period and 
showed no changes of  statistical significance. 
Discussion 
The debate over  the usefulness of  corticosteroid 
therapy in shock has been active for many years 
and has remained largely unresolved. This study is 
directed at a specific area of that debate, namely, 
the usefulness of corticosteroids in the early phases 
of the treatment of  severe (LDlo0) bacteremic 
shock. Significant differences have been noted be- 
tween true bacteremic and pure endotoxin shock 
[10]. We believe that a bacteremia model more 
closely approximates human septic shock than the 
shock state produced by endotoxin alone. 
Previous studies have provided evidence both for 
and against the efficacy of steroids in this type of 
shock. Herman et al. [6] showed no protection 
against diffuse intravascular coagulation and kinin 
release in E. coli shock in the baboon with steroid 
pretreatment.  Our laboratory [5] showed no signifi- 
cant increase in survival, cardiac output,  carbohy- 
drate metabolism preservation,  or cellular mem- 
brane stabilization when MPSS was used without 
fluid resuscitation as the only treatment of septic 
shock in puppies. Coalson et al. [4] showed no 
protection against the microscopic damage to the 
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Fig. 2. Blood pH changes in groups 1 and 5. 
baboon liver, kidney, or adrenal glands with MPSS 
given 15 min after E. coli infusion. 
Hinshaw et al. have reported increased survival 
using a combination of MPSS and antibiotic therapy 
(gentamicin at 9 mg/kg) in both canine [8] and 
primate [7] E. coli shock. This difference in survival 
could not be shown for MPSS treatment alone, 
however. Sambhi and co-workers [11] have shown 
increased cardiac output and decreased peripheral 
resistance after dexamethasone treatment in con- 
trolled bacteremia in humans. 
The experimental model used in this study has 
reliably produced lethal shock in untreated puppies 
in previous studies from our laboratory [5, 9]. The 
use of immature animals may more closely approxi- 
mate clinical shock in the pediatric age range. The 
magnitude of bacteremia is comparable to that used 
in other published studies [12]. Three of the theoret- 
ical advantages of corticosteroid therapy were eval- 
ua ted : the  positive inotropic effect on the heart, 
lysosomal membrane stabilization, and carbohy- 
drate metabolism preservation. The efficacy of 
small- and large-volume fluid therapy was also 
evaluated. 
The large-volume fluid regimens were clearly 
superior to the smaller-volume resuscitation proto- 
cols. Combined survival rate of animals given high- 
volume resuscitation (105% of the EBV) was 43%. 
There were no statistically significant differences 
between the 5% albumin group and those not given 
albumin. In contrast, only 13% of the puppies 
receiving 35% of their EBV as resucitation sur- 
vived. Steroid pretreatment or treatment at the time 
of shock was more effective than treatment delayed 
until 30 min after shock. The survival rate with each 
of these 2 treatments was 47%, compared to only 
7% with delayed therapy. 
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Fig. 3. Blood lactate changes in groups 1 and 5. 
Neither large-volume fluid resuscitation nor early 
steroid treatment, however, was effective alone in 
increasing survival. When the more favorable large- 
volume fluid resuscitation was combined with de- 
layed steroid treatment in groups 7 and 9, there 
were no survivors. Similarly, when the more effec- 
tive early steroid treatment was combined with low- 
volume fluid resuscitation in groups 2 and 5, only a 
10% survival was achieved. It was only by combin- 
ing large-volume fluid resuscitation with early corti- 
costeroid treatment that increased survival result- 
ed. Groups 1, 3, 4, and 6, which combined these 
variables, yielded a 65% survival rate compared to 
only 8% for all other groups. Groups 1 and 3, which 
were pretreated with steroids, showed a combined 
70% survival rate. 
The importance of this trend toward better sur- 
vival with earlier steroid treatment is substantiated 
by looking at cardiac output values. Forty percent 
of the puppies given steroid pretreatment and high- 
volume resuscitation maintained cardiac outputs of 
greater than 60% of control values at the end of the 
experiment and were, therefore, predicted long- 
term survivors. No other surviving animals met this 
criterion. 
The exact mechanism for the increased survival 
documented in this experiment cannot be proven 
from our present data. Strong trends were noted in 
the early steroid treatment-large fluid volume 
groups toward higher cardiac outputs, lower acid 
phosphatase levels, and less acidosis. At various 
points during the experiment, these trends reached 
statistical significance. The survival figures show 
clear statistical significance. 
In conclusion, in this model, a definite increase in 
animal survival has been shown in the acute phase 
of severe septic shock using a combination of high- 
volume fluid resuscitation and the early administra- 
tion of corticosteroids. 
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Fig. 5. Serum glucose changes in groups 1 and 5. 
R6sum6 
Le meilleur traitement du choc septique pr6te en- 
core/~ controverse. Pour le determiner, une 6tude 
exp6rimentale a 6t6 entreprise de mani6re ~ apprd- 
cier l'efficacit6 de la compensation liquidienne et 
celle des corticoides. Pour ce faire, 45 chiots (1,6- 
5,4 kg) furent randomis6s en 9 groupes en combin- 
ant l'administration de 3 types de liquide et celles 
des st6ro~des ~t 3 moments diff6rents. Le cath6t6r- 
isme art6riel, veineux et celui de I'art6re pulmo- 
naire permirent l'6tude continue de l'h6modynami- 
q u e e t  des m6tabolismes. Le choc septique fut 
provoqu6 par l'injection lente d'un bolus constitu6 
de 109/kg d'E. Coli. Le m6thylprednisolone (30 
mg/kg) fut employ6 30 minutes avant l'injection, au 
moment du choc ou encore apr6s le choc. 
D6s que le d~bit sanguin fut r6duit de la moiti6, la 
r6animation par apport liquidien fut assur6e suivant 
3 protocoles diff6rents: injection de solution de 
Ringer enrichi de 5% d'albumine (35% du volume 
sanguin ou 105% du volume sanguin), solution de 
Ringer pur (105% du volume sanguin). 
Les resultats furent les suivants: l'administration 
pr6coce des stdroides fut plus efficace que radmin- 
istration tardive, se traduisant par un taux respectif 
de survie de 47% dans le premier cas et de 7% dans 
la seconde 6ventualit6. De faqon identique, rinjec- 
tion importante de liquide se solda par un taux de 
survie de 43% alors que celui de l'injection limitde 
ne ddpassa pas 7%. Cependant, ni la corticoth6rapie 
pr6coce, ni la compensation liquidienne importante 
n'augmenta par elle-meme la survie. Aucun des 
chiots qui furent soumis ~t la corticoth6rapie pr6- 
coce mais ne requrent que peu de liquide ne surv6- 
cut. I1 en fut de meme lorsque le chiot rebut un 
apport liquidien important et fut soumis & la corti- 
coth6rapie tardive. C'est seulement en combinant la 
corticoth6rapie prdcoce et un apport liquidien im- 
portant que le taux de survie fut am61ior6: 70% 
quand la corticoth6rapie fut entreprise avant le 
choc, 60% lorsque les st6roides furent inject6s au 
moment ou le choc fut provoqu6. 
Le choc est susceptible d'etre jugul6 seulement 
par l'administration prdcoce de corticoides et par 
un apport liquidien important; telle est la conclusion 
des auteurs. 
Resumen 
E1 tratamiento 6ptimo del shock s6ptico sigue 
siendo motivo de controversia. Con el objeto de 
evaluar la eficacia de la resucitaci6n con liquido y la 
administraci6n de corticoesteroides, se acomet/o el 
siguiente estudio experimental. Cuarenta y cinco 
cachorros (1.6-5.4 kg) fueron divididos al azar en 9 
grupos generados por la combinaci6n de 3 difer- 
entes regfmenes de l/quidos y 3 diferentes progra- 
mas para la administraci6n de esteroides. El cate- 
terismo arterial, venoso y de arteria pulmonar per- 
miti6 la monitorfa continua hemodin~mica y 
metab61ica. El shock s6ptico fue inducido mediante 
la infusi6n lenta de un bolo de 109/kg de microor- 
ganismos E. coli. Se administr6 metilprednisolona 
(30 mg/kg) 30 minutos antes de la infusi6n bacter- 
iana, o en el momento del shock, o 30 minutos 
despu6s del shock. Una vez que el d6bito cardiaco 
hubo descendido a menos del 50% de los valores de 
control, uno de tres reg/menes de resucitaci6n fue 
iniciado: albtimina al 5% en lactato de Ringer (LR) a 
raz6n de 35% del volumen sangufneo estimado 
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(VSE), LR a raz6n de 105% VSE,  o albfimina al 5% 
en LR a raz6n de 105% VSE. 
A1 combinar los grupos, se vi6 que el tratamiento 
precoz con esteroide era mils efectivo que el trata- 
miento tardfo, con supervivencias respectivas de 
47% y 7% a los 180 minutos. En forma similar, los 
grupos de resucitaci6n con volumen alto lograron 
43% de supervivencia,  en comparaci6n con 13% 
para los que fueron manejados con menor volumen 
de liquido. Sin embargo, ni la terapia con esteroide 
ni la terapia con alto volumen de liquido demos- 
traron de por  si ser capaces de aumentar  la supervi- 
vencia. A pesar  del pretratamiento con esteroide, 
ninguno de los cachorros  a los que se administr6 la 
infusi6n de menor volumen sobrevivi6. Asf mismi, 
a pesar de la resucitaci6n con alto volumen de 
lfquido, no hubo sobrevivientes cuando 6sta fue 
combinada con tratamiento tardfo con esteroide 
(demorado por 30 minutos). $61o mediante la com- 
binaci6n de la administraci6n precoz de esteroide 
con la terapia de alto volumen de liquido se logr6 
una supervivencia notoriamente aumentada: 60% 
con el tratamiento simultfineo con esteroide, y 70% 
con el pretratamiento con esteroide. 
En consecuencia,  se demostr6 un aumento defin- 
ido en la supervivencia de los animales en el per- 
fodo agudo de shock s6ptico utilizando una combin- 
aci6n de resucitaci6n con alto volumen de lfquido y 
la administraci6n precoz  de esteroides. 
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Invited Commentary 
H. Harlan Stone, M.D. 
University of Maryland, Baltimore, Maryland, U.S.A. 
Reports  on the usefulness of steroids in the treat- 
ment of  septic shock continue to appear in print 
despite the fact that only 1 appropriately controlled, 
statistically valid clinical trial has shown true bene- 
fit in the final ou tcome once such shock has become 
established [1]. More  than 50 similar investigations 
in humans alone have failed to reflect any long-term 
reduction in mortality rate. Although many impor- 
tant parameters of critical organ function are im- 
proved by steroid administration to the patient or 
experimental  animal in septic shock, eventual 
chances for survival remain about the same; only a 
prolongation of life to inevitable death has been the 
result. A complete bibliography of  these studies 
carried out on experimental  animals would com- 
prise easily more than a thousand articles. Almost 
all of  the reports have documented a significant 
protection by pretreatment  and usually some reduc- 
tion in mortality rate if the steroid is administered at 
the time of, or within a very  few minutes of, the 
onset of  the shock episode [2]. Any delay of more 
than 5 min or so has consistently eliminated any 
impact on survival by steroid therapy,  that is, with 
